TUREAC-T Trademark
TUREAC-T is a USPTO trademark filed by Liling biopharmaceuticals (Suzhou) Co., Ltd. Status: Registered.
Trademark Facts
| Mark | TUREAC-T |
|---|---|
| Serial Number | 97437045 |
| Registration Number | 7100501 |
| Status | Registered |
| Filing Date | 2022-05-31 |
| Registration Date | 2023-07-04 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Liling biopharmaceuticals (Suzhou) Co., Ltd |
| Prosecution Events | 11 |
| Latest Event | WOAR on 2025-01-11 |
Goods & Services
Immunostimulants; Biological preparations for the treatment of cancer; Disinfecting wipes; First aid kits; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents